Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300154
- Awardee
-
New England Biolabs, Inc. UEI EDKJNT8DADG8
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,112
Award facts
- Contract value 100% obligated
- $7,112.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Ipswich, MA 01938, USA
Award details come from SAM.gov/FPDS.
About this award
New England Biolabs, Inc., headquartered in Ipswich, Massachusetts, received a Blanket Purchase Agreement (BPA) call order valued at $7,112.25 from a civilian federal agency under the Office of the Director for the procurement of drugs and biologicals. Awarded on February 18, 2016, with an ultimate completion date of December 31, 2016, this firm fixed price contract represents a purchase order for specialized molecular biology products and reagents. As a leading manufacturer of life sciences research tools, New England Biolabs supplied advanced biological materials used in genomics, infectious disease research, and molecular biology investigations to support federal research initiatives.
The contract was issued without a set-aside designation and serves as a call order against a larger BPA vehicle, reflecting the typical procurement approach utilized by federal agencies for routine purchases of specialized laboratory supplies. New England Biolabs' product portfolio under such agreements includes NEBNext library preparation kits, RNA and DNA sequencing reagents, PCR reagents, and various enzymatic kits commonly required by National Institutes of Health institutes and other federal research organizations. This award exemplifies the company's established role as a critical supplier of molecular biology products to the federal research community, supporting ongoing biomedical investigations across multiple agency missions.
Quick answers
Who was awarded contract HHSN26300154?
HHSN26300154 was awarded to New England Biolabs, Inc. by Office of the Director (National Institutes of Health) on February 18, 2016.
How much is contract HHSN26300154 worth?
The government has obligated $7,112 on HHSN26300154.
Is contract HHSN26300154 an order under another contract?
Yes. HHSN26300154 is a BPA call under HHSN263201100018B, a blanket purchase agreement.
Was contract HHSN26300154 competed?
The extent of competition for HHSN26300154 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award